In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

False Advertising Insurance Among Options For Changing Supplement Industry

This article was originally published in The Tan Sheet

Executive Summary

Insurance brokers specializing in dietary supplement firms seek new coverage avenues as many manufacturers have cleaned up their act and lowered their product liability risk.

You may also be interested in...



DMAA Supplements Banned In U.K., Hamstrung In U.S.

The Medicines and Healthcare products Regulatory Agency bans use of dimethylamylamine in the United Kingdom. Meanwhile, FDA has stopped short of an all-out ban, though retailers and insurance carriers largely have turned their backs on DMAA.

DMAA Supplements Banned In U.K., Hamstrung In U.S.

The Medicines and Healthcare products Regulatory Agency bans use of dimethylamylamine in the United Kingdom. Meanwhile, FDA has stopped short of an all-out ban, though retailers and insurance carriers largely have turned their backs on DMAA.

Arbitrary Or Not, Prop 65 Standards Look Likely To Continue – Experts

Firms marketing food and supplement products in California should expect Proposition 65 enforcement actions to continue because, even as industry calls for FDA to intervene, chances for relief will not come soon, experts say

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel